Preliminary analysis of immune responses in patients enrolled in a Phase II trial of cyclophosphamide with allogenic dribble vaccine alone (DPV-001) or with GM-CSF or imiquimod for adjuvant treatment of stage IIIa or IIIb NSCLC

Gardado en:
Detalles Bibliográficos
Publicado en:J Immunother Cancer
Main Authors: Sanborn, Rachel, Boulmay, Brian, Li, Rui, Spieler, Bradley, Happel, Kyle, Paustian, Christopher, Mougdil, Tarsem, Feng, Zipei, Dubay, Christopher, Fisher, Brenda, Koguchi, Yoshinobu, Aung, Sandra, Mederos, Eileen, Bifulco, Carlo, McNamara, Michael, Bahjat, Keith S, Redmond, William, Ochoa, Augusto C, Hu, Hong Ming, Fox, Bernard, Urba, Walter, Hilton, Traci
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2015
Assuntos:
Poster Presentation
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4652497/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2051-1426-3-S2-P435
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares